Inflection Biosciences
Dr Andrew Leishman is Director at Immunoconsulting Limited with over 20 years small and large molecule drug discovery and development experience, from target identification through to clinical development. He has worked with several pharmaceutical companies including PPL Therapeutics, Grunenthal and AstraZeneca (MedImmune) to deliver therapies targeting components of the immune system that are undergoing clinical trials across several therapy areas.
This person is not in the org chart
This person is not in any offices
Inflection Biosciences
Inflection Biosciences Ltd is an early stage, drug development company with a focus on discovering and developing innovative small molecule therapeutics addressing major unmet needs in cancer.